[HTML][HTML] Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?

RS O'Neill, A Stoita - World journal of gastroenterology, 2021 - ncbi.nlm.nih.gov
Pancreatic cancer (PC) is a leading cause of cancer related mortality on a global scale. The
disease itself is associated with a dismal prognosis, partly due to its silent nature resulting in …

The emerging roles of CEACAM6 in human cancer

G Wu, D Wang, F Xiong, Q Wang… - International …, 2024 - spandidos-publications.com
Carcinoembryonic antigen (CEA)-related cell adhesion molecule 6 (CEACAM6) is a cell
adhesion protein of the CEA family of glycosyl phosphatidyl inositol anchored cell surface …

Structure and mechanism of cancer-associated N-acetylglucosaminyltransferase-V

M Nagae, Y Kizuka, E Mihara, Y Kitago… - Nature …, 2018 - nature.com
Abstract N-acetylglucosaminyltransferase-V (GnT-V) alters the structure of specific N-
glycans by modifying α1-6-linked mannose with a β1-6-linked N-acetylglucosamine branch …

3D Structure and Function of Glycosyltransferases Involved in N-glycan Maturation

M Nagae, Y Yamaguchi, N Taniguchi… - International journal of …, 2020 - mdpi.com
Glycosylation is the most ubiquitous post-translational modification in eukaryotes. N-glycan
is attached to nascent glycoproteins and is processed and matured by various glycosidases …

True significance of N-acetylglucosaminyltransferases GnT-III, V and α1, 6 fucosyltransferase in epithelial-mesenchymal transition and cancer

N Taniguchi, Y Ohkawa, K Maeda, Y Harada… - Molecular Aspects of …, 2021 - Elsevier
It is well known that numerous cancer-related changes occur in glycans that are attached to
glycoproteins, glycolipids and proteoglycans on the cell surface and these changes in …

Delivery of a BET protein degrader via a CEACAM6-targeted antibody–drug conjugate inhibits tumour growth in pancreatic cancer models

Y Nakazawa, M Miyano, S Tsukamoto, H Kogai… - Nature …, 2024 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) has the worst prognosis of all cancers. To
improve PDAC therapy, we establish screening systems based on organoid and co-culture …

Aberrant N-glycosylation in cancer: MGAT5 and β1,6-GlcNAc branched N-glycans as critical regulators of tumor development and progression

M de-Souza-Ferreira, ÉE Ferreira… - Cellular Oncology, 2023 - Springer
Background Changes in protein glycosylation are widely observed in tumor cells. N-glycan
branching through adding β1, 6-linked N-acetylglucosamine (β1, 6-GlcNAc) to an α1, 6 …

[HTML][HTML] Changes in protein glycosylation in head and neck squamous cell carcinoma

C Liao, J An, Z Tan, F Xu, J Liu, Q Wang - Journal of Cancer, 2021 - ncbi.nlm.nih.gov
Glycosylation is an important posttranslational modification of proteins, and it has a profound
influence on diverse life processes. An abnormal polysaccharide structure and mutation of …

Identification of SPP1 as an extracellular matrix signature for metastatic castration-resistant prostate cancer

X Pang, R Xie, Z Zhang, Q Liu, S Wu, Y Cui - Frontiers in oncology, 2019 - frontiersin.org
Resistance to androgen deprivation therapy (ADT) is the main challenge for advanced fatal
prostate cancer (PCa), which can gradually develop into metastatic castration-resistant …

[HTML][HTML] Overexpression of CEACAM6 activates Src-FAK signaling and inhibits anoikis, through homophilic interactions in lung adenocarcinomas

EY Kim, YJ Cha, S Jeong, YS Chang - Translational oncology, 2022 - Elsevier
Among carcinoembryonic antigen-related cell adhesion molecule (CEACAM) family
proteins, CEACAM6 has received less attention than CEACAM5 and its presence and role in …